Company / EPS (Diluted)
Vericel EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.07
FY2025
5-year range
-$0.35 / $0.06
FY2021-FY2025
Trend
+80.0%
vs FY2024
Sector context
#52 of 204
Health Care
What the data says
Vericel's eps (diluted) of $-0.07 is higher than 75% of companies in the Health Care sector (FY2025). EPS (Diluted) returned to growth in FY2025 after 2 years of decline, reaching $-0.07.
Based on SEC 10-K filings.
-0.07 in FY2025.
Improved from $-0.16 to $-0.07 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 204This company -$0.07 Sector average -$0.89
▼
+92.1% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 80.0% year-over-year.
- Ranks #52 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2022.
- Lowest eps (diluted) in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.07 | +80.0% |
| FY2024 | -$0.35 | -118.7% |
| FY2023 | -$0.16 | -366.7% |
| FY2022 | $0.06 | +127.3% |
| FY2021 | -$0.22 | -10.0% |
| FY2020 | -$0.20 | +0.0% |
| FY2019 | -$0.20 | +4.8% |
| FY2018 | -$0.21 | +78.4% |
| FY2017 | -$0.97 | +56.5% |
| FY2016 | -$2.23 | +67.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026